Literature DB >> 33415337

A multi-institutional survey of the quality of life after treatment for uterine cervical cancer: a comparison between radical radiotherapy and surgery in Japan.

Yuko Kaneyasu1,2, Hisaya Fujiwara3,4, Tetsuo Nishimura5, Hideyuki Sakurai6, Tomoko Kazumoto7,8, Hitoshi Ikushima9, Takashi Uno10, Sunao Tokumaru11,12, Yoko Harima13, Hiromichi Gomi14, Takafumi Toita15,16, Midori Kita17, Shin-Ei Noda18,19, Takeo Takahashi20, Shingo Kato18, Ayako Ohkawa6,21, Akiko Tozawa-Ono22, Hiroki Ushijima8, Yoko Hasumi23,24, Yasuyuki Hirashima25, Yuzuru Niibe26, Tomio Nakagawa1, Tomoyuki Akita27, Junko Tanaka27, Tatsuya Ohno19.   

Abstract

This study aimed to research the post-treatment quality of life (QOL) between radiotherapy (RT)- and operation (OP)-treated early cervical cancer survivors, using separate questionnaires for physicians and patients. We administered an observational questionnaire to patients aged 20-70 years old with Stages IB1-IIB cervical cancer who had undergone RT or OP and without recurrence as outpatients for ≥6 months after treatment. We divided 100 registered patients equally into two treatment groups (n = 50 each). The average age was 53 and 44 years in the RT and OP groups, respectively. The RT group included 34 and 66% Stage I and II patients, respectively, whereas the OP group included 66 and 34% Stage I and II patients, respectively. The OP group included 58% of patients with postoperative RT. Combination chemotherapy was performed in 84 and 48% of patients in the RT and OP groups, respectively. On the physicians' questionnaire, we observed significant differences in bone marrow suppression (RT) and leg edema (OP). On the patients' questionnaire, significantly more patients had dysuria and leg edema in the OP group than in the RT group, and severe (Score 4-5) leg edema was significantly higher in the post-operative RT group than in the OP only group. The frequency of sexual intercourse decreased after treatment in both groups. On the patients' questionnaire, there were no significant differences between the two groups regarding sexual activity. These findings are useful to patients and physicians for shared decision-making in treatment choices. The guidance of everyday life and health information including sexual life after treatment is important.
© The Author(s) 2021. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology.

Entities:  

Keywords:  quality of life; questionnaire; radiotherapy; sexuality; surgery; uterine cervical cancer

Year:  2021        PMID: 33415337      PMCID: PMC7973450          DOI: 10.1093/jrr/rraa107

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  25 in total

1.  An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer.

Authors:  Q D Pieterse; C P Maas; M M ter Kuile; M Lowik; M A van Eijkeren; J B M Z Trimbos; G G Kenter
Journal:  Int J Gynecol Cancer       Date:  2006 May-Jun       Impact factor: 3.437

2.  The patients' perspective on physical symptoms after radiotherapy for cervical cancer.

Authors:  M Klee; I Thranov; D Machin Prof
Journal:  Gynecol Oncol       Date:  2000-01       Impact factor: 5.482

3.  Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer.

Authors:  F Landoni; A Maneo; A Colombo; F Placa; R Milani; P Perego; G Favini; L Ferri; C Mangioni
Journal:  Lancet       Date:  1997-08-23       Impact factor: 79.321

4.  Quality of life and sexual functioning in cervical cancer survivors.

Authors:  Michael Frumovitz; Charlotte C Sun; Leslie R Schover; Mark F Munsell; Anuja Jhingran; J Taylor Wharton; Patricia Eifel; Therese B Bevers; Charles F Levenback; David M Gershenson; Diane C Bodurka
Journal:  J Clin Oncol       Date:  2005-10-20       Impact factor: 44.544

5.  The impact of radiotherapy for carcinoma of the cervix on sexual function assessed using the LENT SOMA scales.

Authors:  Susan E Davidson; Meriel P Burns; Jacqueline A Routledge; Ric Swindell
Journal:  Radiother Oncol       Date:  2003-09       Impact factor: 6.280

6.  Comparison of surgery or radiotherapy on complications and quality of life in patients with the stage IB and IIA uterine cervical cancer.

Authors:  Wei-Chung Hsu; Na-Na Chung; Yu-Chia Chen; Lai-Lei Ting; Po-Ming Wang; Pao-Chun Hsieh; Shu-Ching Chan
Journal:  Gynecol Oncol       Date:  2009-07-16       Impact factor: 5.482

7.  Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population.

Authors:  Sang Yoon Park; Duk-Soo Bae; Joo Hyun Nam; Chong Taik Park; Chi-Heum Cho; Jong Min Lee; Myung Kyung Lee; Soo Hyun Kim; Sang Min Park; Young Ho Yun
Journal:  Cancer       Date:  2007-12-15       Impact factor: 6.860

8.  The light and electron microscopic features of early and late phase radiation-induced proctitis.

Authors:  N Y Haboubi; P F Schofield; P L Rowland
Journal:  Am J Gastroenterol       Date:  1988-10       Impact factor: 10.864

9.  Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer.

Authors:  Pernille T Jensen; Mogens Groenvold; Marianne C Klee; Ingrid Thranov; Morten A Petersen; David Machin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-07-15       Impact factor: 7.038

10.  Early stage cervical cancer: psychosocial and sexual outcomes of treatment.

Authors:  A Cull; V J Cowie; D I Farquharson; J R Livingstone; G E Smart; R A Elton
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

View more
  2 in total

Review 1.  Management of Early-Stage Cervical Cancer: A Literature Review.

Authors:  Yasmin Medeiros Guimarães; Luani Rezende Godoy; Adhemar Longatto-Filho; Ricardo Dos Reis
Journal:  Cancers (Basel)       Date:  2022-01-24       Impact factor: 6.639

2.  Development of accurate temperature regulation culture system with metallic culture vessel demonstrates different thermal cytotoxicity in cancer and normal cells.

Authors:  Chikahiro Imashiro; Haruka Takeshita; Takashi Morikura; Shogo Miyata; Kenjiro Takemura; Jun Komotori
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.